聚合酵素鏈鎖反應(PCR) 市場：按產品類型、最終用戶和地區分類

Polymerase Chain Reaction Market, By Product Type, By End User, By Geography

出版日期: 2026年02月12日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，聚合酵素鏈鎖反應（PCR）市場規模將達191.4億美元，2033年將達260.4億美元。預計從2026年到2033年，其複合年成長率將達到4.5%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	191.4億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	4.50%	預計金額（2033 年）	260.4億美元

聚合酵素鏈鎖反應(PCR) 是一種廣泛應用的 DNA 擴增技術，能夠擴增數千至數百萬個特定 DNA 序列拷貝。 PCR 產業正將其重心從宏觀系統轉向微型設備的研發。微型設備具有許多優勢，例如減少患者用血量、縮短反應時間、降低成本，因為許多微流體設備採用廉價聚合物製造。 PCR 在各種診斷和研究應用中的聚合酵素鏈鎖反應普及、基因治療研發投入的不斷成長以及聚合酵素鏈鎖反應技術的持續進步，預計將在預測期內推動市場成長。 PCR聚合酵素鏈鎖反應的快速發展，使得高靈敏度和最佳化的檢測儀器得以實現；慢性病和感染疾病的日益普及；以及基因治療和分子檢測研究經費的增加，預計也將推動全球聚合酵素鏈鎖反應市場在預測期內的成長。

市場動態

全球聚合酵素鏈鎖反應(PCR) 市場預計在預測期內將顯著成長。這主要歸功於其在眾多領域的應用不斷擴展，包括中耳炎、結核病和萊姆病等感染疾病的診斷；DNA 指紋鑑定和親子鑑定等法醫學；以及 DNA定序、DNA 克隆和基因表現等各種分子研究應用。聚合酵素鏈鎖反應(PCR) 也可用於遺傳疾病的診斷，並能檢測遺傳性和自發性基因突變。

聚合酵素鏈鎖反應（PCR）在個人化醫療中得到應用，用於輔助選擇合適的治療方法，尤其適用於存在影響患者對特定治療方法（例如癌症治療）反應的基因突變的患者。 PCR 也被用於肺癌和大腸癌的研究，以分析癌症患者的分子特徵，從而提供個人化的癌症治療。即時PCR在多種核酸擴增中具有高靈敏度和特異性，並應用於從感染疾病研究、藥物基因體學化的結果。 PCR 在醫學和醫學研究各個領域的廣泛應用，預計將在預測期內推動全球聚合酵素鏈鎖反應（PCR）市場的成長。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球聚合酵素鏈鎖反應(PCR) 市場中主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球聚合酵素鏈鎖反應(PCR) 市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球聚合酵素鏈鎖反應(PCR) 市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

F.Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
BioMerieux, SA
Enzo Life Science, Inc.
Abbott Laboratories
Takara Bio Inc.
Becton, Dickinson and Company
Danaher Corporation

第8章分析師建議

機會
分析師意見
Coherent Opportunity Map (COM)

第9章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI1546

Polymerase Chain Reaction Market is estimated to be valued at USD 19.14 Bn in 2026 and is expected to reach USD 26.04 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 19.14 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.50%	2033 Value Projection:	USD 26.04 Bn

Polymerase chain reaction (PCR) is extensively used for DNA amplification technique. It generates thousands to millions of copies of a particular DNA sequence. The PCR industry is shifting its focus away from macro-scale systems and is focused on developing the micro-scale devices. Micro-scale devices offer various benefits such as micro-scale sample sizes requires less blood from patients, it takes less reaction time and also offers cost-effective benefits, as many microfluidic devices are manufactured from inexpensive polymers. Increasing adoption of polymerase chain reaction in various diagnostic and research application, growing research and development funding in gene therapy, and continuous technological advancement in polymerase chain reaction are expected to drive growth of the market over the forecast period. Rapid technological advancement in the polymerase chain reaction to deliver highly sensitive and optimized detection instrument, increasing prevalence of chronic and infectious disease, and growing research funding in gene therapy and molecular testing is expected to drive growth of the global polymerase chain reaction market over the forecast period.

Market Dynamics

The global polymerase chain reaction market is projected to witness significant growth over the forecast period, owing to its wide and increasing applications in various fields, which include diagnosis of infectious diseases, such as middle ear infections, tuberculosis, Lyme disease, in forensics, including DNA fingerprinting, paternity testing and in various other molecular research applications, such as DNA sequencing, DNA cloning, and gene expression. Polymerase chain reaction is used for diagnosis of genetic disease, allowing to detect inherited genetic change or spontaneous genetic mutation.

PCR is used in personalized medicine to help patients in selecting certain treatments, such as in cancer when patients have a genetic change that makes a patient more or less likely to respond to a certain treatment. Polymerase chain reaction is used to study the molecular characteristics in cancer patients, in order to deliver tailored cancer therapy in lung and colorectal cancer. Real-time PCR offers higher sensitivity and specificity in various range of nucleic acid amplification, which is used in wide research areas including infectious disease research, translational medicine to applied biology. Furthermore, technological advancement in the PCR reagents, assay, instruments and analysis tools, help to provide more customized results in various research areas, such as stem cell research, oncology and genetic disease research, pharmaceutical analytics, pharmacogenomics, plant science research and agriculture biotechnology. Such wide numbers of PCR applications in the different field of healthcare and medical research areas, are expected to drive growth of the global polymerase chain reaction market over the forecast period.

Key features of the study

This report provides an in-depth analysis of the global polymerase chain reaction market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global polymerase chain reaction market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMerieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company and Danaher Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global polymerase chain reaction market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymerase chain reaction market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Instruments
- Real Time PCR
- Digital PCR
- Others
- Reagents & Consumables
End User Insights (Revenue, USD Bn, 2026 - 2033)
- Clinical Diagnostics
- Academic and Research Laboratories
- Forensic Laboratories
- Others
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
- F.Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- BioMerieux, S.A.
- Enzo Life Science, Inc.
- Abbott Laboratories
- Takara Bio Inc.
- Becton, Dickinson and Company
- Danaher Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Polymerase Chain Reaction Market, By Product Type
- Global Polymerase Chain Reaction Market, By End User
- Global Polymerase Chain Reaction Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

4. Global Polymerase Chain Reaction Market, By Product Type, 2020-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
- Segment Trends
  - Real Time PCR
  - Digital PCR
  - Others
Reagents & Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Polymerase Chain Reaction Market, By End User, 2020-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Academic and Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Forensic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Polymerase Chain Reaction Market, By Region, 2020 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

F.Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioMerieux, S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Enzo Life Science, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies